| Company
| Aggregate Score
| P/E ratio
| Gross margin
| EBIT margin
| ROA
| Net income per employee
|
| Intelligent Bio Solutions Inc.
|
| -0.04
| 43.1%
| -331.7%
| -108.2%
| -€188.56K
|
| Vimian Group AB (publ)
|
| 6.1
| 68.6%
| 14.3%
| 2.8%
| €26.08K
|
| Fulgent Genetics, Inc.
|
| -15
| 41.2%
| -22.5%
| -3.5%
| -€28.40K
|
| Lumibird SA
|
| 27
| 9.6%
| 10.6%
| 2.5%
| €10.44K
|
| NanoRepro AG
|
| -10
| 41.6%
| -80.4%
| -5.2%
| -€92.99K
|
| Exagen Inc.
|
| -8.3
| 59.9%
| -19.6%
| -30.3%
| -€79.04K
|
| Verici Dx plc
|
| -0.0093
| 100.0%
| -182.9%
| -78.4%
| -€268.25K
|
| Proteome Sciences plc
|
| -0.027
| -0.7%
| -50.1%
| -39.9%
| -€106.11K
|
| Illumina, Inc.
|
| 20
| 66.2%
| 18.3%
| 11.4%
| €68.00K
|
| IDEXX Laboratories, Inc.
|
| 41
| 61.7%
| 31.3%
| 30.3%
| €81.04K
|
| Yourgene Health Plc
|
| -0.014
| 62.4%
| -78.5%
| -23.6%
| -€52.44K
|
| Syneos Health, Inc.
|
| 62
| 22.1%
| 5.4%
| 0.9%
| €2.15K
|
| Myriad Genetics, Inc.
|
| -1.2
| 70.4%
| -50.1%
| -58.3%
| -€127.00K
|
| Exact Sciences Corporation
|
| -11
| 67.4%
| -32.3%
| -16.7%
| -€124.06K
|
| Spectral Medical Inc.
|
| -12
| 59.8%
| -461.5%
| -389.0%
| -€459.89K
|
| OpGen, Inc.
|
| 3.7
| 100.8%
| 41.2%
| 119.9%
| €115.32K
|
| Medpace Holdings, Inc.
|
| 20
| 31.1%
| 21.5%
| 24.7%
| €63.68K
|
| Standard BioTools Inc.
|
| -3.1
| 47.9%
| -96.6%
| -23.8%
| -€180.94K
|
| Waters Corporation
|
| 31
| 62.4%
| 26.5%
| 13.3%
| €74.07K
|
| Trinity Biotech plc
|
| -0.35
| 32.1%
| -42.0%
| -37.4%
| -€85.11K
|
| Meridian Bioscience, Inc.
|
| -546
| 56.6%
| 2.1%
| -0.6%
| -€3.40K
|
| Interpace Biosciences, Inc.
|
| 0.75
| 64.6%
| 13.3%
| 40.0%
| €37.60K
|
| Mettler-Toledo International Inc.
|
| 29
| 59.7%
| 29.1%
| 23.7%
| €45.32K
|
| Star Equity Holdings, Inc.
|
| -1
| 32.9%
| -1.8%
| -5.4%
| -€28.29K
|
| Precipio, Inc.
|
| -13
| 47.5%
| -9.7%
| -5.9%
| -€20.15K
|
| PerkinElmer, Inc.
|
| 46
| 59.1%
| 12.0%
| 2.0%
| €12.75K
|
| ANGLE plc
|
| -1.1
| 62.3%
| -627.7%
| -87.3%
| -€151.98K
|
| Synlab AG
|
| 27
| 49.8%
| 5.2%
| 1.9%
| €3.31K
|
| OPKO Health, Inc.
|
| -7.5
| 38.6%
| -17.5%
| -7.1%
| -€40.76K
|
| Bionano Genomics, Inc.
|
| -0.32
| 48.1%
| -127.9%
| -48.8%
| -€341.64K
|
| Biocartis Group NV
|
| -0.4
| 41.6%
| -71.6%
| -60.1%
| -€129.03K
|
| Applied DNA Sciences, Inc.
|
| -0.064
| 39.6%
| -406.1%
| -373.5%
| -€699.90K
|
| Danaher Corporation
|
| 41
| 59.5%
| 19.0%
| 4.4%
| €49.83K
|
| IQVIA Holdings Inc.
|
| 21
| 33.8%
| 13.4%
| 4.5%
| €12.51K
|
| Diaceutics PLC
|
| -0.7
| 86.1%
| -6.4%
| -3.4%
| -€9.47K
|
| Neuronetics, Inc.
|
| -5.7
| 50.4%
| -29.2%
| -30.2%
| -€53.32K
|
| RadNet, Inc.
|
| -339
| 9.6%
| 3.0%
| -0.3%
| -€1.00K
|
| Eurofins Scientific SE
|
| 34
| 14.2%
| 13.7%
| 2.9%
| €4.93K
|
| Lonza Group AG
|
| 57
| 32.9%
| 15.3%
| 3.9%
| €44.21K
|
| CareDx, Inc
|
| 18
| 67.3%
| 14.7%
| 14.1%
| €81.87K
|
| Invitae Corporation
|
| -0.0037
| 27.1%
| -303.5%
| -269.2%
| -€735.29K
|
| Twist Bioscience Corporation
|
| -27
| 50.7%
| -36.2%
| -12.1%
| -€72.86K
|
| Guardant Health, Inc.
|
| -15
| 63.8%
| -49.0%
| -31.2%
| -€173.10K
|
| Neogen Corporation
|
| -1.2
| 43.8%
| -121.7%
| -30.9%
| -€310.28K
|
| MDxHealth SA
|
| -6.5
| 61.4%
| -25.6%
| -11.7%
| -€63.25K
|
| DiaSorin S.p.A.
|
| 27
| 65.7%
| 23.1%
| 6.6%
| €58.60K
|
| Thermo Fisher Scientific Inc.
|
| 24
| 42.0%
| 17.2%
| 6.4%
| €45.61K
|
| Personalis, Inc.
|
| -6.9
| 26.7%
| -117.1%
| -30.4%
| -€281.17K
|
| Charles River Laboratories International, Inc.
|
| -88
| 32.1%
| 3.5%
| -1.1%
| -€3.87K
|
| Agilent Technologies, Inc.
|
| 26
| 52.4%
| 21.3%
| 10.2%
| €63.16K
|
